ProShare Advisors’s Pliant Therapeutics PLRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,080
| Closed | -$20.4K | – | 2159 |
|
|
2025
Q1 | $20.4K | Sell |
15,080
-3,851
| -20% | -$5.2K | ﹤0.01% | 2037 |
|
|
2024
Q4 | $249K | Buy |
18,931
+4,570
| +32% | +$60.2K | ﹤0.01% | 1765 |
|
|
2024
Q3 | $161K | Buy |
14,361
+2,982
| +26% | +$33.4K | ﹤0.01% | 1786 |
|
|
2024
Q2 | $122K | Sell |
11,379
-3,110
| -21% | -$33.4K | ﹤0.01% | 1631 |
|
|
2024
Q1 | $216K | Buy |
14,489
+1,203
| +9% | +$17.9K | ﹤0.01% | 1631 |
|
|
2023
Q4 | $241K | Buy |
13,286
+2,033
| +18% | +$36.8K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $195K | Buy |
11,253
+76
| +0.7% | +$1.32K | ﹤0.01% | 1477 |
|
|
2023
Q2 | $203K | Buy |
+11,177
| New | +$203K | ﹤0.01% | 1536 |
|
|
2022
Q1 | – | Sell |
-10,335
| Closed | -$139K | – | 2280 |
|
|
2021
Q4 | $139K | Sell |
10,335
-424
| -4% | -$5.7K | ﹤0.01% | 2145 |
|
|
2021
Q3 | $182K | Sell |
10,759
-1,933
| -15% | -$32.7K | ﹤0.01% | 1812 |
|
|
2021
Q2 | $370K | Buy |
12,692
+1,364
| +12% | +$39.8K | ﹤0.01% | 1748 |
|
|
2021
Q1 | $446K | Buy |
+11,328
| New | +$446K | ﹤0.01% | 1522 |
|